Macquarie University’s research ambitions are grounded in achieving world-changing impact today and leading the breakthroughs of tomorrow.
Macquarie University’s research ambition is unapologetically global: to deliver world-leading research with world-changing impact. Central to this ambition is our recognition that how research is conducted is every bit as important as where it is done.
In an era defined by complexity, uncertainty and global interdependence, meaningful solutions no longer arise from single sets of knowledge or isolated excellence. Instead, they emerge from consilience: the purposeful integration of diverse ways of knowing, spanning science, engineering, medicine, humanities and social sciences (see Breakout Box below)
Drawing on Edward O. Wilson’s use of consilience as the ‘jumping together’ of knowledge across domains, consilience is not simply more collaboration or alignment by design alone. It is the capacity of individuals, groups, and organisations to surface shared problems, integrate diverse perspectives, coordinate effectively, and generate outcomes that exceed the sum of individual contributions.
Consilience depends on people and culture as much as on structures and incentives. It depends on shared language and frameworks, boundary spanning roles, collaboration and learning across disciplines and sectors, and everyday coordination practices that allow knowledge to move, combine and resonate. Organisational design can enable this work, but cannot substitute for it.
Consilience is not a fixed state to be achieved, but rather a readiness within systems. It is the conditions under which diverse expertise can connect productively when it matters most.
Source: Why Australia’s R&D Review Won’t Work Without the Science and Art of Consilience, 16 March 2026
Consilience is not simply a rhetorical commitment at Macquarie, but a guiding principle. For more than a decade, we have deliberately reshaped our research architecture, culture and investment model to prioritise research communities and collectives at scale, built on and coordinating distinct disciplinary expertise. This approach enables sustained collaboration, accelerates discovery, and supports translation from fundamental insight to real-world application. It also positions Macquarie as a partner of choice for international consortia addressing complex, mission-driven challenges.
Our consilient research ecosystem is organised around five future-shaping research priorities, articulated in ‘Research Strategy 2035: World-leading Research; World-changing Impact’ and aligned with national and global agendas, including Horizon Europe:
Healthy people
Resilient societies
Prosperous economies
Secure planet
Innovative technologies
Together, these priorities provide long-term coherence and focus, while remaining broad enough to accommodate emerging fields and frontier innovation.
Research centres driving impact across five future-shaping research priorities
At the heart of this consilient ecosystem sits Macquarie University’s 11 flagship Research Centres – our enduring, interdisciplinary research collectives that concentrate expertise, infrastructure and partnerships to deliver excellence at scale.
Healthy people
Macquarie has a long-standing reputation globally for its strength in advancing health, wellbeing and quality of life across the lifespan.
The Hearing Research Centre brings together neuroscience, linguistics, engineering, health and social sciences to transform hearing health through inclusive, translational research. The Hearing Centre actively partners with people with lived experience, community organisations, government, and industry, ensuring findings inform policy and clinical practice locally and internationally.
The Lifespan Health and Wellbeing Research Centre advances social, emotional and cognitive health from early childhood to older age, translating evidence into clinical programmes, policy advice and community interventions. Signature initiatives include evidence based programmes, targeting anxiety, depression, neurological conditions and healthy ageing, delivered across clinical, community and digital settings.
Complementing this, research teams within the Motor Neuron Disease Research Centre investigate how disease-related genes and proteins drive motor neuron degeneration, identify biomarkers and diagnostic approaches, and test new drug and gene-based strategies. The Centre integrates patient-linked clinical research, a neurodegenerative disease biobank, genomics, bioinformatics and molecular therapeutics to accelerate diagnosis and treatment discovery, with the shared goal of creating a world free of motor neuron disease.
Resilient societies
Addressing social resilience requires deep insight into ethics, agency, cognition and performance in fast-changing contexts. The Ethics and Agency Research Centre undertakes applied, multidisciplinary research on ethics, justice and responsibility in response to technological, legal, environmental, and social change, directly informing policy and governance. The Centre is strongly oriented towards real-world impact. Its research focuses on the ethics of artificial intelligence (AI) and digital technologies, misinformation and rational agency, human rights and free speech, animal and environmental ethics, health and healthcare ethics, and moral and legal responsibility within justice systems.
The Minds and Intelligences Research Centre bridges neuroscience, data science and the social sciences to investigate how intelligence and decision-making operate across biological, artificial and organisational systems, by comparing how animal brains, computer systems, corporations and collective groups process complex information and arrive at effective solutions. Through this work, the Centre informs the design of smarter technologies, improves organisational decision practices, and strengthens societal responses to complex challenges.
The Performance and Expertise Research Centre focuses on sustaining high performance, resilience and safety in real-world environments, translating research into simulation-based training, psychosocial interventions and capability frameworks for industry and government. The Centre collaborates with partners to define what elite performance looks like in specific tasks, diagnose capability gaps across individuals and teams, and design training and workplace solutions that improve outcomes and build future readiness.
Prosperous economies
Macquarie researchers are actively shaping the economic systems needed for sustainable prosperity. The Transforming Energy Markets Research Centre brings together economics, finance, engineering and law to redesign energy markets for a net-zero future. Its work addresses regulation, social acceptability and emerging technologies such as hydrogen and distributed energy systems. The Centre delivers evidence-based insights that guide energy market design and analytics, regulation and social acceptability, transformative energy technologies, and carbon emissions management, including pricing, trading, and storage. The Centre is committed to fair outcomes for households and communities and supporting the adoption of emerging energy sources.
Secure planet
Understanding and protecting our planet – and our place beyond it – is a defining strength at Macquarie. The Smart Green Cities Research Centre develops collaborative, evidence-based solutions to improve urban liveability, resilience and sustainability, recognising cities as complex, interconnected systems. With the future prosperity and wellbeing of cities, and those who live in them, under increasing pressure from intersecting environmental, social, and resource challenges, the Centre works across disciplines to improve how cities function, and communities experience them.
The Astrophysics and Space Technologies Research Centre advances fundamental discovery and technological innovation through data-intensive astronomy, instrumentation and space technologies. This contributes to our understanding of the universe while enabling safer, more capable space systems. The Centre channels cross-disciplinary research into projects spanning extragalactic astronomy, stellar and planetary astrophysics, interstellar medium, theoretical and computational astrophysics, instrumentation and space technologies, and novel spacecraft optical systems.
Innovative technologies
Frontier technologies underpin progress across all domains. The Applied AI Research Centre translates artificial intelligence and data science into real-world impact across sectors, including health, education, finance, sustainability, and law, while partnering closely with industry to shape intelligent systems. To do this, the Centre’s research spans automation, data curation, cognitive technologies, smart systems, IoT enabled processes, and data storytelling.
The Future Communications Research Centre advances secure, resilient and high-performance connectivity, spanning quantum communications, 5/6G networks, satellite systems and edge AI, with applications ranging from remote healthcare to autonomous systems and national security. Working closely with industry and government, the Centre builds communication systems that are trustworthy by design – prioritising privacy, security, resilience, energy efficiency and inclusivity to define the future of universal, resilient and secure communications in Australia and globally.
From consilient strengths to BioInnovation at scale
Individually, Macquarie’s Research Centres represent mature areas of internationally competitive excellence. Collectively, they provide a platform for coordination across health, technology, ethics, policy and industry, enabling the University to tackle higher order, global questions that no single field can address alone. This capacity for integration – of foundational discovery, enabling technologies and societal insight – creates fertile ground for ambitious, mission-driven initiatives operating at the intersection of disciplines.
One such initiative is BioInnovation: a flagship consilient endeavour that draws on Macquarie’s strengths across life sciences, artificial intelligence, engineering, materials, ethics and governance to reimagine how biology is understood, designed and responsibly deployed.
BioInnovation at the confluence: Engineering the living future
As we move toward 2050, life sciences, information technologies, photonics, nanotechnology, materials science and engineering are fusing into a powerful innovation paradigm that is reshaping how we understand, design, and engineer life itself. At Macquarie University, this confluence defines a bold vision for BioInnovation.
A new era for biology
For most of its modern history, biology has been a science of observation and understanding. That is changing. Advances in AI, quantum computing, synthetic biology, RNA science, and chip engineering are converging with extraordinary momentum, transforming biology into a precision engineering discipline in which living systems can be designed, simulated, predicted and programmed.
What distinguishes this moment is not simply the power of these technologies, but how they interact. Computation has become a creative partner in biological design, while biology itself is emerging as a substrate for computation. For instance, DNA and RNA are no longer understood solely as carriers of genetic information; they are increasingly recognised as biological algorithms capable of serving as ultra dense data storage media and computational platforms.
Underpinning many of these developments is a concept researchers describe as SynBio×AI – the convergence of synthetic biology with artificial intelligence, quantum computing, robotics and automation. In this integrated cycle, AI systems generate hypotheses and design biological solutions; automated, high throughput biofoundries execute those designs at scale; and engineering biology platforms translate them into functional biological systems. Discovery, in effect, is becoming a predictive, design led enterprise rather than a process of trial and error.
This convergence is already unlocking transformative opportunities. DNA and RNA are emerging as biological algorithms, ultra-dense data storage media, and computational substrates. Cell on a chip and biological machines are redefining drug discovery and diagnostics. Engineered synthetic genes, chromosomes and genomes in designer microbes are enabling sustainable manufacturing, while bio integrated sensors and devices are reshaping how we interact with the physical world. Together, these advances point toward a future of digital twins of living systems, personalised medicine, and entirely new computing architectures.
RNA and DNA research sit at the epicentre of this convergence. Once regarded primarily as a transient messenger between DNA and protein, RNA is now understood as a sophisticated functional material that folds into precise three-dimensional architectures, catalyses biochemical reactions, regulates gene expression, and can be engineered to sense, compute and respond to its cellular environment. Synthetic RNA circuits, riboswitches, and aptamers are enabling programmable control of biological processes with a precision that was inconceivable a decade ago.
Nowhere is this more consequential than in vaccine development, where RNA technology is redefining the economics of early-stage immunogen design. RNA’s speed and modularity allow multi-antigen constructs targeting conserved virulence proteins to move rapidly from computational design through to in vitro validation, compressing timelines that once required years.
Another compelling example of how foundational research powers step change innovation can be found in one of biology’s most enduring model organisms – yeast. Long a bridge between basic biology and applied engineering, yeast research at the frontier of genome synthesis and computational design has taken scientists from reading genomes to rewriting them, highlighting the cumulative value of decades of sustained scientific investment.
Responsibility at the heart of innovation
As these possibilities expand, so does the responsibility to develop them wisely. History has shown that technological foresight without broader insight is fragile. The most enduring advances are those grounded in deep understanding, guided by ethical and societal awareness, and shaped by thoughtful governance.
This is why the integration of political, economic, social, technological, environmental and legal considerations (or the PESTEL framework) is increasingly seen as essential to BioInnovation. Embedding these dimensions into research and development from the outset helps ensure that innovation serves society, earns public trust and achieves real world uptake. As biological and digital systems converge ever more closely, responsible innovation is not an afterthought; it is a prerequisite.
Macquarie University’s BioInnovation Initiative
At Macquarie University in Sydney, Australia, this global convergence is being channelled into a coherent and ambitious BioInnovation Initiative. The University’s vision is to lead internationally by harnessing the confluence of biotechnology, information technology, chip technology and nanotechnology to deliver transformative impact across health, agriculture, environmental sustainability, and advanced technology.
Macquarie’s approach is built on interconnected research pillars spanning synthetic biology, RNA biology, AI, quantum, semiconductor technologies, and advanced photonics — all underpinned by PESTEL considerations to ensure that innovation is developed responsibly and with societal benefit in mind.
Macquarie is expanding its world leading capabilities in this space, leveraging strengths in molecular and cellular biology, gene editing, AI predicted RNA therapeutics, semiconductor and chip design, economics, law, the humanities and social sciences.
Crucially, flagship infrastructure located on Macquarie’s campus – including the Australian Genome Foundry (AGF), the RNA Research and Pilot Manufacturing Facility, and advanced semiconductor laboratories – enables seamless integration across the full design-build-test-learn cycle that defines modern engineering biology. The RNA Facility provides end-to-end capability from Good Manufacturing Practice (GMP)-aligned synthesis and lipid nanoparticle (LNP) formulation through to clinical-grade manufacture for Phase 1–3 trials across both human and animal applications. Anchoring the upstream design capability that feeds this pipeline, Macquarie develops the cloud-based computational tools for designing novel mRNA vaccines and RNA therapeutics for human and animal health, creating the intellectual property that the manufacturing facility is now positioned to translate into clinical and commercial reality.
Looking ahead
The advances now emerging from BioInnovation point towards a future of digital twins of living systems, truly personalised medicine and entirely new computing architectures. Macquarie University’s ambition is to be at the forefront of that future – addressing society’s most pressing challenges through consilient world class, interdisciplinary research that advances knowledge and delivers lasting social and economic value.
The future of innovation will be neither purely biological nor purely digital. It will be a dynamic fusion of both. That is the promise of BioInnovation — and it is already taking shape.
Please Note: This is a Commercial Profile
Please note, this article will also appear in the 26th edition of our quarterly publication.
Source link
